NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition

International Journal of Cancer

Volumn 134, Issue 10, 2014, Pages 2294-2304

  Jin, Yujuan ^a   Li, Fei ^a   Zheng, Chao ^a   Wang, Ye ^a   Fang, Zhaoyuan ^a   Guo, Chenchen ^a   Wang, Xujun ^b   Liu, Hongyan ^a   Deng, Lei ^b   Li, Cheng ^b   Wang, Hongda ^c   Chen, Haiquan ^d,e   Feng, Yan ^a   Ji, Hongbin ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b TONGJI UNIVERSITY   (China)

^c CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^d FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

epithelial mesenchymal transition; lung cancer; metastasis; NEDD9

Indexed keywords

FOCAL ADHESION KINASE; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MALE; MELANOMA; METASTASIS POTENTIAL; MOUSE; NEDD9 GENE; NEURAL STEM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATOR GENE; TUMOR INVASION; UPREGULATION;

EPITHELIAL-MESENCHYMAL TRANSITION; LUNG CANCER; METASTASIS; NEDD9;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; MICE, NUDE; MICE, TRANSGENIC; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTOME;

EID: 84895923153     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28568     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Kim M, Gans JD, Nogueira C, et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 2006; 125: 1269-81.
3. Singh M, Cowell L, Seo S, et al. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle. Cell Biochem Biophys 2007; 48: 54-72.
4. Sanz-Moreno V, Gadea G, Ahn J, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008; 135: 510-23.
5. Natarajan M, Stewart JE, Golemis EA, et al. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 2006; 25: 1721-32.
6. Izumchenko E, Singh MK, Plotnikova OV, et al. NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res 2009; 69: 7198-206.
7. Feng Y, Wang Y, Wang Z, et al. The CRTC1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss. Cancer Res 2012; 72: 6502-11.
8. Ji H, Ramsey MR, Hayes DN, et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 2007; 448: 807-10.
9. Jackson EL, Willis N, Mercer K, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001; 15: 3243-8.
10. Zheng C, Sun YH, Ye XL, et al. Establishment and characterization of primary lung cancer cell lines from Chinese population. Acta Pharmacol Sin 2011; 32: 385-92.
11. Shao R, Bao S, Bai X, et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 2004; 24: 3992-4003.
12. Naldini L, Blomer U, Gage FH, et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93: 11382-8.
13. Wu ZY, Zhan WH, Li JH, et al. Expression of E-cadherin in gastric carcinoma and its correlation with lymph node micrometastasis. World J Gastroenterol 2005; 11: 3139-43.
14. Thiery JP, Sleeman JP,. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-42.
15. Yang J, Weinberg RA,. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14: 818-29.
16. Fang X, Cai Y, Liu J, et al. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene 2011; 30: 4707-20.
17. Irie HY, Pearline RV, Grueneberg D, et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 2005; 171: 1023-34.
18. Liebner S, Cattelino A, Gallini R, et al. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol 2004; 166: 359-67.
19. Peinado H, Del Carmen Iglesias-de, la Cruz M, Olmeda D, et al. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J 2005; 24: 3446-58.
20. Zhang H, Singh RR, Talukder AH, et al. Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway. Genes Dev 2006; 20: 2943-8.
21. Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931-40.
22. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436: 518-24.
23. Kong C, Wang C, Wang L, et al. NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer. PLoS One 2011; 6: e22666.
24. Tikhmyanova N, Golemis EA,. NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation. PLoS One 2011; 6: e22102.
25. Miao Y, Li AL, Wang L, et al. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, beta-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer. Pathol Oncol Res 2013; 19: 281-6.
26. O'Neill GM, Seo S, Serebriiskii IG, et al. A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9. Cancer Res 2007; 67: 8975-9.
27. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455: 1069-75.
28. Gao B, Sun Y, Zhang J, et al. Spectrum of LKB1, EGFR, and KRAS mutations in Chinese lung adenocarcinomas. J Thorac Oncol 2010; 5: 1130-5.
29. Chen Z, Cheng K, Walton Z, et al. A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature 2012; 483: 613-7.
30. Carretero J, Shimamura T, Rikova K, et al. Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell 2010; 17: 547-59.
31. Pugacheva EN, Golemis EA,. HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks. Cell Cycle 2006; 5: 384-91.
32. Law SF, O'Neill GM, Fashena SJ, et al. The docking protein HEF1 is an apoptotic mediator at focal adhesion sites. Mol Cell Biol 2000; 20: 5184-95.
33. O'Neill GM, Fashena SJ, Golemis EA,. Integrin signalling: a new Cas(t) of characters enters the stage. Trends Cell Biol 2000; 10: 111-9.
34. O'Neill GM, Golemis EA,. Proteolysis of the docking protein HEF1 and implications for focal adhesion dynamics. Mol Cell Biol 2001; 21: 5094-108.
35. Seo S, Asai T, Saito T, et al. Crk-associated substrate lymphocyte type is required for lymphocyte trafficking and marginal zone B cell maintenance. J Immunol 2005; 175: 3492-501.